Microsomal oxidative stress induced by NADPH is inhibited by nitrofurantoin redox biotranformation

References

• D’Arcy PF. Nitrofurantoin. Drug Intell Clin Pharm 1985;19:540–547.
   PubMedGoogle Scholar
• Urbina JA. Specific chemotherapy of Chagas disease: relevance, current limitations and new approaches. Acta Trop 2010;115:55–68.
   PubMed Web of Science ®Google Scholar
• Gleckman R, Alvarez S, Joubert DW. Drug therapy reviews: nitrofurantoin. Am J Hosp Pharm 1979;36:342–351.
   PubMedGoogle Scholar
• Westphal JF, Vetter D, Brogard JM. Hepatic side-effects of antibiotics. J Antimicrob Chemother 1994;33:387–401.
   PubMed Web of Science ®Google Scholar
• Triantafyllou K, Vlachogiannakos J, Ladas SD. Gastrointestinal and liver side effects of drugs in elderly patients. Best Pract Res Clin Gastroenterol 2010;24:203–215.
   PubMed Web of Science ®Google Scholar
• Symons T, Tocher JH, Tocher DA, Edwards DI. Electrochemical studies of nitroheterocyclic compounds of biological interest. VII. Effect of electrode material. Free Radic Res Commun 1991;14:33–40.
   Web of Science ®Google Scholar
• Squella JA, Letelier ME, Lindermeyer L, Nuñez-Vergara LJ. Redox behaviour of nifuroxazide: generation of the one- electron reduction product. Chem Biol Interact 1996;99: 227–238.
   Google Scholar
• Boiani M, Piacenza L, Hernández P, Boiani L, Cerecetto H, González M, Denicola A. Mode of action of nifurtimox and N-oxide-containing heterocycles against Trypanosoma cruzi: is oxidative stress involved?. Biochem Pharmacol 2010;79: 1736–1745.
   PubMed Web of Science ®Google Scholar
• Hall BS, Bot C, Wilkinson SR. Nifurtimox activation by trypanosomal type I nitroreductases generates cytotoxic nitrile metabolites. J Biol Chem 2011;286:13088–13095.
   PubMed Web of Science ®Google Scholar
• McOsker CC, Fitzpatrick PM. Nitrofurantoin: mechanism of action and implications for resistance development in common uropathogens. J Antimicrob Chemother 1994;33:23–30.
   PubMed Web of Science ®Google Scholar
• Murataliev MB, Feyereisen R, Walker FA. Electron transfer by diflavin reductases. Biochim Biophys Acta 2004;1698:1–26.
   PubMed Web of Science ®Google Scholar
• Deller S, Macheroux P, Sollner S. Flavin-dependent quinone reductases. Cell Mol Life Sci 2008;65:141–160.
   Google Scholar
• Zenser TV, Mattammal MB, Palmier MO, Davis BB. Microsomal nitroreductase activity of rabbit kidney and bladder: implications in 5-nitrofuran-induced toxicity. J Pharmacol Exp Ther 1981;219:735–740.
   PubMed Web of Science ®Google Scholar
• Moreno SN, Mason RP, Docampo R. Reduction of nifurtimox and nitrofurantoin to free radical metabolites by rat liver mitochondria. Evidence of an outer membrane-located nitroreductase. J Biol Chem 1984;259:6298–6305.
   Google Scholar
• Viodé C, Bettache N, Cenas N, Krauth-Siegel RL, Chauvière G, Bakalara N, Périé J. Enzymatic reduction studies of nitroheterocycles. Biochem Pharmacol 1999;57:549–557.
   PubMed Web of Science ®Google Scholar
• Wang Y, Gray JP, Mishin V, Heck DE, Laskin DL, Laskin JD. Role of cytochrome P450 reductase in nitrofurantoin-induced redox cycling and cytotoxicity. Free Radic Biol Med 2008; 44:1169–1179.
   Google Scholar
• Bartel LC, Montalto de Mecca M, Castro JA. Nitroreductive metabolic activation of some carcinogenic nitro heterocyclic food contaminants in rat mammary tissue cellular fractions. Food Chem Toxicol 2009;47:140–144.
   Google Scholar
• Fernandez Villamil SH, Dubin M, Brusa MA, Duran RP, Perissinotti LJ, Stoppani AO. Generation of radical anions of nifurtimox and related nitrofuran compounds by ascorbate. Free Radic Res Commun 1990;10:351–360.
   PubMed Web of Science ®Google Scholar
• Letelier ME, Izquierdo P, Godoy L, Lepe AM, Faúndez M. Liver microsomal biotransformation of nitro-aryl drugs: mechanism for potential oxidative stress induction. J Appl Toxicol 2004;24:519–525.
   PubMed Web of Science ®Google Scholar
• Letelier ME, Entrala P, López-Alarcón C, González-Lira V, Molina-Berríos A, Cortés-Troncoso J, et al. Nitroaryl-1,4- dihydropyridines as antioxidants against rat liver microsomes oxidation induced by iron/ascorbate, nitrofurantoin and naphthalene. Toxicol In Vitro 2007;21:1610–1618.
   PubMed Web of Science ®Google Scholar
• Dubin M, Grinblat L, Fernandez Villamil SH, Stoppani AO. Nitrofuran inhibition of microsomal lipid peroxidation. FEBS Lett 1987;220:197–200.
   PubMed Web of Science ®Google Scholar
• Dubin M, Fernandez Villamil SH, Paulino de Blumenfeld M, Stoppani AO. Inhibition of microsomal lipid peroxidation and cytochrome P-450-catalyzed reactions by nitrofuran compounds. Free Radic Res Commun 1991;14:419–431.
   PubMed Web of Science ®Google Scholar
• Guay DRP. Contemporary management of uncomplicated urinary tract infections. Drugs 2008;68:1169–1205.
   PubMed Web of Science ®Google Scholar
• Witten CM. Pulmonary toxicity of nitrofurantoin. Arch Phys Med Rehabil 1989;70:55–57.
   Google Scholar
• Bialas MC, Shetty HG, Houghton J, Woods F, Routledge PA. Nitrofurantoin rechallenge and recurrent toxicity. Postgrad Med J 1997;73:519–520.
   Google Scholar
• Goemaere NNT, Grijm K, Van Hal PTW, Den Bakker MA. Nitrofurantoin-induced pulmonary fibrosis: a case report. J Med Case Rep 2008;2:169.
   PubMedGoogle Scholar
• Penn RG, Griffin JP. Adverse reactions to nitrofurantoin in the United Kingdom, Sweden, and Holland. Br Med J 1982; 284:1440–1442.
   Google Scholar
• Paiva LA, Wright PJ, Koff RS. Long-term hepatic memory for hypersensitivity to nitrofurantoin. Am J Gastroenterol 1992; 87:891–893.
   Google Scholar
• Jacknowitz AI, Le Frock JL, Prince RA. Nitrofurantoin polyneuropathy: report of two cases. Am J Hosp Pharm 1977;34:759–762.
   Google Scholar
• Gait JE. Hemolytic reactions to nitrofurantoin in patients with glucose-6-phosphate dehydrogenase deficiency: theory and practice. DICP 1990;24:1210–1213.
   Google Scholar
• Martin WJ. Nitrofurantoin: evidence for the oxidant injury of lung parenchymal cells. Am Rev Respir Dis 1983;127:482–486.
   PubMedGoogle Scholar
• Martin WJ. Nitrofurantoin. Potential direct and indirect mechanisms of lung injury. Chest 1983;83:51S–52S.
   Google Scholar
• Minchin RF, Ho PC, Boyd MR. Reductive metabolism of nitrofurantoin by rat lung and liver in vitro. Biochem Pharmacol 1986;35:575–580.
   PubMed Web of Science ®Google Scholar
• Rossi L, Silva JM, McGirr LG, O’Brien PJ. Nitrofurantoin-mediated oxidative stress cytotoxicity in isolated rat hepatocytes. Biochem Pharmacol 1988;37:3109–3117.
   Google Scholar
• Hochstein P, Ernster L. ADP-activated lipid peroxidation coupled to the TPNH oxidase system of microsomes. Biochem Biophys Res Commun 1963;12:388–394.
   PubMed Web of Science ®Google Scholar
• Orrenius S, Dallner G, Ernster L. Inhibition of the TPNH-linked lipid peroxidation of liver microsomes by drugs undergoing oxidative demethylation. Biochem Biophys Res Commun 1964;14:329–334.
   PubMed Web of Science ®Google Scholar
• Danielson PB. The cytochrome P450 superfamily: biochemistry, evolution and drug metabolism in humans. Curr Drug Metab 2002;3:561–597.
   PubMed Web of Science ®Google Scholar
• Guengerich FP. Cytochrome p450 and chemical toxicology. Chem Res Toxicol 2008;21:70–83.
   PubMed Web of Science ®Google Scholar
• Hollenberg PF, Kent UM, Bumpus NN. Mechanism-based inactivation of human cytochromes p450s: experimental characterization, reactive intermediates, and clinical implications. Chem Res Toxicol 2008;21:189–205.
   PubMed Web of Science ®Google Scholar
• Kramer MA, Tracy TS. Studying cytochrome P450 kinetics in drug metabolism. Expert opin Drug Metab Toxicol 2008;4: 591–603.
   PubMed Web of Science ®Google Scholar
• Finzi JK, Donato JL, Sucupira M, De Nucci G. Determination of nitrofuran metabolites in poultry muscle and eggs by liquid chromatography-tandem mass spectrometry. J Chromatogr B 2005;824:30–35.
   PubMed Web of Science ®Google Scholar
• Rodziewicz L. Determination of nitrofuran metabolites in milk by liquid chromatography-electrospray ionization tandem mass spectrometry. J Chromatogr B 2008;864:156–160.
   PubMed Web of Science ®Google Scholar
• Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265–275.
   PubMed Web of Science ®Google Scholar
• Young IS, Trimble ER. Measurement of malondialdehyde in plasma by high performance liquid chromatography with fluorimetric detection. Ann Clin Biochem 1991;28: 504–508.
   PubMed Web of Science ®Google Scholar
• Omura T, Sato R. The carbon monoxide-binding pigment of liver microsomes. II. Solubilization, purification, and properties. J Biol Chem 1964;239:2379–2385.
   PubMed Web of Science ®Google Scholar
• Letelier ME, Faúndez M, Jara-Sandoval J, et al. Mechanisms underlying the inhibition of the cytochrome P450 system by copper ions. J Appl Toxicol 2009;29:695–702.
   Google Scholar
• Letelier ME, Del Villar E, Sanchez E. Drug tolerance and detoxicating enzymes in Octodon degus and Wistar rats. A comparative study. Comp Biochem Physiol C 1985;80: 195–198.
   Google Scholar
• Estabrook RW. A passion for P450s (rememberances of the early history of research on cytochrome P450). Drug Metab Dispos 2003;31:1461–1473.
   PubMed Web of Science ®Google Scholar
• Schultz HJ, Edson RS. Cystitis treatment in women, circa 2011: new role for an old drug. Mayo Clinic Proc 2011;86: 477–479.
   Google Scholar
• Karpman E, Kurzrock EA. Adverse reactions of nitrofurantoin, trimethoprim and sulfamethoxazole in children. J Urol 2004;172:448–453.
   PubMed Web of Science ®Google Scholar
• Olivard J, Rose GM, Klein GM, Heotis JP. Metabolic and photochemical hydroxylation of 5-nitro-2-furancarboxaldehyde derivatives. J Med Chem 1976;19:729–731.
   PubMed Web of Science ®Google Scholar
• Jonen HG. Reductive and oxidative metabolism of nitrofurantoin in rat liver. Naunyn Schmiedebergs Arch Pharmacol 1980;315:167–175.
   PubMedGoogle Scholar
• Jonen HG, Oesch F, Platt KL. 4-Hydroxylation of nitrofurantoin in the rat. A 3-methylcholanthrene-inducible pathway of a relatively nontoxic compound. Drug Metab Dispos 1980; 8:446–451.
   PubMed Web of Science ®Google Scholar